Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 18  •  10:22AM ET
36.47
Dollar change
+0.06
Percentage change
0.16
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y20.42% Total Holdings61 Perf Week-2.15%
SponsorSimplify ETF ETF Type Tagsequity Return% 3Y10.51% AUM344.61M Perf Month-0.55%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter16.22%
Index- Average Maturity Tags- Return% 10Y 52W High38.02 -4.08% Perf Half Y24.81%
Index Weighting Commodity Type Tags- Return% SI 52W Low26.10 39.74% Perf YTD22.96%
Active/Passive Quant Type Tags- Flows% 1M24.52% Volatility1.34% 1.50% Perf Year19.89%
Dividend TTM0.16 (0.45%) ESG Type Tags- Flows% 3M93.56% ATR (14)0.55 Perf 3Y32.81%
Dividend Ex-DateSep 25, 2025 Dividend Type Sector/Theme Flows% YTD89.34% RSI (14)53.32 Perf 5Y-
Dividend Gr. 3/5Y98.60% - Structure Type Region Flows% 1Y Beta0.74 Perf 10Y-
Expense0.51% Growth/Value SMA20-1.26% Flows% 3Y Rel Volume0.80 Prev Close36.41
Inverse/Leveraged Market Cap SMA504.36% Flows% 5Y Avg Volume191.29K Price36.47
IPOOct 08, 2021 Option/ShortYes / Yes SMA20017.77% Trades Volume29,481 Change0.16%
Nov-26-25 10:00AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
08:30AM Loading…
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Feb-28-24 01:30PM
Dec-15-23 07:00PM
Oct-31-23 03:00AM
Oct-12-22 09:05AM
May-17-22 08:56AM
08:57AM Loading…
Dec-28-21 08:57AM
Simplify Health Care ETF seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 - 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.